Patient surveys: a tick box for advocacy
Register now for the Tools for Change webinar series: “How to interpret and leverage survey results for effective advocacy” 10 March, 10am GMT and 7pm GMT
Monthly Archives: February 2016
First Ebola, now Zika: the inconvenient truths about battling emerging diseases
In the second time in as many years, the World Health Organization (WHO) has declared a new global public health emergency. Zika virus is predicted to infect millions in the next few months as it sweeps across the globe. Dr Kevin Bardosh talks more about this emerging disease.
1Living with the double stigma of drug use and HIV in Pakistan
In this final post of the miniseries focusing on harm reduction in Asia and the Pacific, authors Dr Anne Bergenstrom and Dr Manzoor ul Haq from the United Nations Office of Drugs and Crime (UNODC), paint a picture of drug use and HIV and the issues being faced, in Pakistan.
Why harm reduction and drug policy reform need each other
Second in a miniseries on harm reduction in Asia and the Pacific, Gloria Lai from the International Drug Policy Consortium briefly discusses policy reform in the run up to the UN General Assembly Special Session on the world drug problem.
Viral hepatitis testing: time to innovate – and deliver!
Exercise debates, nuclear disaster, and modern fertility questions: examining the Altmetric coverage
Different approaches to drug policy and the Asian HIV epidemic
Following the recent launch of the series ‘Harm reduction in Asia and the Pacific’, Dr. Alex Wodak, President of the Australian Drug Law Reform Foundation, here writes a very honest account of efforts to control HIV among and from people who inject drugs in Asia.